TallyHQ
github
Client · LDA

FRESENIUS KABI USA LLC

6 filings 17 bills mentioned 1 registrants 5 quarters ~$2,947,941 reported
Client ID
205669

Bills lobbied on

Bills referenced in this client's quarterly filings, ranked by filing count.

HR 3269
ETHIC Act
HCR
4
S 2276
ETHIC Act
HCR
4
S 1954
Biosimilar Red Tape Elimination Act
HCR
3
HR 5526
Biosimilar Red Tape Elimination Act
HCR
3
S 1414
Expedited Access to Biosimilars Act
HCR
3
HR 4317
PBM Reform Act of 2025
HCR
2
S 1041
Affordable Prescriptions for Patients Act
HCR
2
S 43
Skinny Labels, Big Savings Act
HCR
2
HR 4570
Interagency Patent Coordination and Improvement Act of 2025
HCR
2
S 1553
PREVAIL Act
HCR
2
HR 3160
PREVAIL Act
HCR
2
S 1097
Interagency Patent Coordination and Improvement Act of 2025
HCR
2
S 1096
Preserve Access to Affordable Generics and Biosimilars Act
HCR
2
HR 2214
DRUG Act
HCR
2
S 2658
Medication Affordability and Patent Integrity Act
HCR
1
S 2305
FRONT Act
HCR
1
S 2296
National Defense Authorization Act for Fiscal Year 2026
HCR
1

Registrants

Lobbying firms that filed on behalf of this client.

FRESENIUS KABI USA LLC 6

Source: Senate LDA quarterly filings (LD-2). Bill mentions extracted from free-text "specific issues" descriptions.